P. Croarkin

Publications272
h-index26
Citations2,616
Highly Influential Citations110
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • Z. Daskalakis
  • 409 Publications • 21,424 Citations
  • P. Fitzgerald
  • 688 Publications • 30,175 Citations
  • M. Frye
  • 684 Publications • 30,068 Citations
  • Á. Pascual-Leone
  • 1,204 Publications • 103,724 Citations
  • Publications
  • Influence
Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment
View on Elsevier
Evidence for GABAergic inhibitory deficits in major depressive disorder
View on Elsevier
A Diffusion Tensor Imaging Study in Children With ADHD, Autism Spectrum Disorder, OCD, and Matched Controls: Distinct and Non-Distinct White Matter Disruption and Dimensional Brain-Behavior…
TLDR
D disruption in interhemispheric circuitry (i.e., fractional anisotropy alterations in the corpus callosum) is identified as a shared feature of ASD, ADHD, and OCD, however, fractionalAnisotography alterations may be more widespread and severe in ASD and ADHD than in OCD.
View on PubMed
KETAMINE FOR TREATMENT‐RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
TLDR
This clinical review of ketamines will assess the evidence‐based use of ketamine and initial clinical implications of further development of a potentially novel treatment for rapid reduction of symptoms in depressed patients.
View on Wiley
Functional Connectivity of Brain Structures Correlates with Treatment Outcome in Major Depressive Disorder
TLDR
Among 13 participants with 8 weeks follow-up data, connectivity measures in several regions, especially the subcallosal cortex, were highly correlated with treatment outcome, suggesting connectivity measures could provide a means to evaluate how likely a patient is to respond to an antidepressant treatment.
View on PubMed
Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder.
TLDR
Findings suggest that major depressive disorder in children and adolescents is associated with increased intracortical facilitation and excessive glutamatergic activity.
View on PubMed
Using simultaneous repetitive Transcranial Magnetic Stimulation/functional Near Infrared Spectroscopy (rTMS/fNIRS) to measure brain activation and connectivity
View on Elsevier
Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents
View on Elsevier
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
TLDR
Young patients can develop neuroleptic malignant syndrome during treatment with atypical antipsychotics, and clinicians should maintain a high index of suspicion.
View on PubMed
Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
TLDR
While adolescents reporting substantial insomnia were less likely to respond to antidepressant treatment than those without insomnia, children were more responsive to fluoxetine when they had insomnia.
View on PubMed
...
...